Stock Events

Stock Events

Stablecoin Development 

$0.8808
105
-$0.14-13.65% 20:00 Today
+$0.02+1.93%20:16After hours

Statistics

Day High
1.015
Day Low
0.8784
52W High
95.8
52W Low
0.84
Volume
6,744,035
Avg. Volume
12,652,607
Mkt Cap
44.58M
P/E Ratio
-
Dividend Yield
784.31%
Dividend
6.91

Upcoming

Dividends

784.31%Dividend Yield
Sep 2025
$4.00
Sep 2025
$4.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Nov 5Expected
Q2 2018
Q3 2018
Q4 2018
Q3 2025
Q1 2026
Q2 2026
Next
-1.15
-0.77
-0.38
-0
Expected EPS
-0.6
Actual EPS
N/A

Financials

-120,215.93%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
521,000Revenue
-626.33MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDEV. It's not an investment recommendation.
Rocket Lab
4
RKLB
Bitcoin
3
BTC.CRYPTO
Vertiv
3
VRT
Eos Energy Enterprises
3
EOSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ocular Therapeutix
OCUL
Mkt Cap1.53B
Ocular Therapeutix focuses on developing treatments for eye diseases, directly competing with Novabay's eye care products.
National Vision
EYE
Mkt Cap1.3B
National Vision Holdings operates in the eye care market, offering products that can be seen as alternatives to Novabay's offerings.
Alcon
ALC
Mkt Cap30.82B
Alcon specializes in eye care products, including surgical, vision care, and ophthalmic pharmaceuticals, competing across several of Novabay's key areas.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson, through its Vision Care division, competes in the eye health sector, offering products that rival Novabay's.
Pfizer
PFE
Mkt Cap158.45B
Pfizer has a broad range of healthcare products, including treatments for eye conditions that compete with Novabay's pharmaceuticals.
Novartis
NVS
Mkt Cap268B
Novartis offers a wide range of healthcare products, including ophthalmic solutions that compete with Novabay's eye care products.
Bausch Health Companies
BHC
Mkt Cap2.17B
Bausch Health Companies, through its eye health division, directly competes with Novabay in the ophthalmology and optometry markets.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals is involved in developing treatments for eye diseases, offering products that compete with Novabay's portfolio.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie, having acquired Allergan, competes in the eye care sector with a portfolio that includes treatments for various eye conditions, challenging Novabay's market share.

About

Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.
Show More
CEO
Michael Kazley
Employees
4
Country
United States
ISIN
US66987P5089
WKN
000A422LL

Listings

XASE
US
SDEV
BOATS
BOATS
NBY.BOATS
STU
DE
B9PA.STU
MU
DE
B9P1.MU

0 Comments

Share your thoughts

FAQs

What is Stablecoin Development stock price today?▼
The current price of SDEV is $0.88 USD — it has decreased by -13.65% in the past 24 hours. Watch Stablecoin Development stock price performance more closely on the chart.
What is Stablecoin Development stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Stablecoin Development stocks are traded under the ticker SDEV.
Is Stablecoin Development stock price growing?▼
SDEV stock has fallen by -42.81% compared to the previous week, the month change is a +4.86% rise, over the last year Stablecoin Development has showed a -84.55% decrease.
What is Stablecoin Development market cap?▼
Today Stablecoin Development has the market capitalization of 44.58M
When is the next Stablecoin Development earnings date?▼
Stablecoin Development is going to release the next earnings report on November 5, 2026.
What is Stablecoin Development revenue for the last year?▼
Stablecoin Development revenue for the last year amounts to 521,000 USD.
What is Stablecoin Development net income for the last year?▼
SDEV net income for the last year is -626.33M USD.
Does Stablecoin Development pay dividends?▼
Yes, SDEV dividends are paid en. The last dividend per share was 4 . As of today, Dividend Yield (FWD)% is 784.31%.
How many employees does Stablecoin Development have?▼
As of October 16, 2026, the company has 4 employees.
In which sector is Stablecoin Development located?▼
Stablecoin Development operates in the Health & Wellness sector.
When did Stablecoin Development complete a stock split?▼
The last stock split for Stablecoin Development was on February 23, 2026 with a ratio of 1:5.
Where is Stablecoin Development headquartered?▼
Stablecoin Development is headquartered in WEST PALM BEACH, United States.